2023
DOI: 10.1371/journal.pone.0285096
|View full text |Cite|
|
Sign up to set email alerts
|

Perinatal mortality rate and adverse perinatal outcomes presumably attributable to placental dysfunction in (near) term gestation: A nationwide 5-year cohort study

Abstract: Introduction Placental dysfunction can lead to perinatal hypoxic events including stillbirth. Unless there is overt severe fetal growth restriction, placental dysfunction is frequently not identified in (near) term pregnancy, particularly because fetal size is not necessarily small. This study aimed to evaluate, among (near) term births, the burden of hypoxia-related adverse perinatal outcomes reflected in an association with birth weight centiles as a proxy for placental function. Material and method A nati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 36 publications
0
2
0
Order By: Relevance
“…Abnormal fetal growth, i.e., IUGR and fetal overgrowth, is associated with increased perinatal morbidity and mortality 1,2 and is strongly linked to the development of metabolic and cardiovascular disease in childhood and later in life 3–6 . Emerging evidence suggests that changes in placental amino acid transport may contribute to abnormal fetal growth.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Abnormal fetal growth, i.e., IUGR and fetal overgrowth, is associated with increased perinatal morbidity and mortality 1,2 and is strongly linked to the development of metabolic and cardiovascular disease in childhood and later in life 3–6 . Emerging evidence suggests that changes in placental amino acid transport may contribute to abnormal fetal growth.…”
Section: Discussionmentioning
confidence: 99%
“…Optimal fetal growth is of great importance not only for pregnancy outcomes but also for life‐long health. Abnormal fetal growth, i.e., intrauterine growth restriction (IUGR) or fetal growth restriction (FGR) and fetal overgrowth, is associated with increased perinatal morbidity and mortality 1,2 and is strongly linked to the development of metabolic and cardiovascular disease in childhood and later in life 3–6 . Thus, understanding the mechanisms regulating fetal growth could provide a foundation for the development of novel intervention strategies to alleviate important pregnancy complications and the burden of chronic disease in the next generation.…”
Section: Introductionmentioning
confidence: 99%